Diabetes, Obesity and Metabolism

Cover image for Vol. 16 Issue 4

April 2014

Volume 16, Issue 4

Pages i–i, 289–380

  1. ISSUE INFORMATION

    1. Top of page
    2. ISSUE INFORMATION
    3. EDITORIAL
    4. REVIEW ARTICLES
    5. ORIGINAL ARTICLES
    6. RESEARCH LETTER
    1. Issue Information (page i)

      Version of Record online: 3 MAR 2014 | DOI: 10.1111/dom.12202

  2. EDITORIAL

    1. Top of page
    2. ISSUE INFORMATION
    3. EDITORIAL
    4. REVIEW ARTICLES
    5. ORIGINAL ARTICLES
    6. RESEARCH LETTER
  3. REVIEW ARTICLES

    1. Top of page
    2. ISSUE INFORMATION
    3. EDITORIAL
    4. REVIEW ARTICLES
    5. ORIGINAL ARTICLES
    6. RESEARCH LETTER
    1. The cannabinoid receptor 1 and its role in influencing peripheral metabolism (pages 294–304)

      L. O'Keefe, A. C. Simcocks, D. H. Hryciw, M. L. Mathai and A. J. McAinch

      Version of Record online: 10 JUL 2013 | DOI: 10.1111/dom.12144

    2. Diabetic foot infections: state-of-the-art (pages 305–316)

      I. Uçkay, K. Gariani, Z. Pataky and B. A. Lipsky

      Version of Record online: 1 SEP 2013 | DOI: 10.1111/dom.12190

  4. ORIGINAL ARTICLES

    1. Top of page
    2. ISSUE INFORMATION
    3. EDITORIAL
    4. REVIEW ARTICLES
    5. ORIGINAL ARTICLES
    6. RESEARCH LETTER
    1. Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular disease (pages 317–325)

      G. Thomas, K. Khunti, V. Curcin, M. Molokhia, C. Millett, A. Majeed and S. Paul

      Version of Record online: 29 OCT 2013 | DOI: 10.1111/dom.12217

    2. Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance (pages 326–333)

      H. Florez, M. G. Temprosa, T. J. Orchard, K. J. Mather, S. M. Marcovina, E. Barrett-Connor, E. Horton, C. Saudek, X. F. Pi-Sunyer, R. E. Ratner, R. B. Goldberg and for the Diabetes Prevention Program Research Group

      Version of Record online: 29 OCT 2013 | DOI: 10.1111/dom.12220

    3. Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial (pages 334–343)

      H. Denison, C. Nilsson, L. Löfgren, A. Himmelmann, G. Mårtensson, M. Knutsson, A. AL-Shurbaji, H. Tornqvist and J. W. Eriksson

      Version of Record online: 31 OCT 2013 | DOI: 10.1111/dom.12221

    4. Steady-state pharmacokinetics and glucodynamics of the novel, long-acting basal insulin LY2605541 dosed once-daily in patients with type 2 diabetes mellitus (pages 344–350)

      V. P. Sinha, D. C. Howey, S. L. Choi, K. F. Mace and T. Heise

      Version of Record online: 31 OCT 2013 | DOI: 10.1111/dom.12222

      Corrected by:

      ERRATUM: Erratum

      Vol. 16, Issue 9, 877, Version of Record online: 11 AUG 2014

  5. RESEARCH LETTER

    1. Top of page
    2. ISSUE INFORMATION
    3. EDITORIAL
    4. REVIEW ARTICLES
    5. ORIGINAL ARTICLES
    6. RESEARCH LETTER
    1. You have full text access to this OnlineOpen article
      Combined antidiabetic benefits of exenatide and dapagliflozin in diabetic mice (pages 376–380)

      K. Tatarkiewicz, C. Polizzi, C. Villescaz, L. J. D'Souza, Y. Wang, S. Janssen and D. G. Parkes

      Version of Record online: 9 DEC 2013 | DOI: 10.1111/dom.12237

SEARCH

SEARCH BY CITATION